Jesse Smith, MD
Otolaryngology · Fort Worth, TXNPI 1194742791
Payments from drug & device makers
Across 162 payments — averaging $97.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dutch Ophthalmic, USA$9K
- AbbVie$2K
- Organogenesis Inc.$2K
- Merz North America, Inc.$1K
- Stryker$746
- Intersect ENT, Inc.$351
- plus $566 from 11 others
What the payments were for
- Consulting fees$6,00038%
- Speaking & faculty fees$1,80011%
- Travel & lodging$3,06019%
- Food & beverage$4,93831%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dutch Ophthalmic, USA | 5 | $9,060 |
| AbbVie(2 entities) | 91 | $2,020 |
| Organogenesis Inc. | 2 | $1,800 |
| Merz North America, Inc. | 35 | $1,256 |
| Stryker | 9 | $746 |
| Intersect ENT, Inc. | 3 | $351 |
| Pacira Pharmaceuticals Incorporated | 3 | $159 |
| Medtronic | 3 | $99 |
| KARL Storz Endoscopy-america | 1 | $65 |
| Sanofi | 2 | $54 |
| Boston Scientific | 1 | $43 |
| Acclarent, Inc | 2 | $43 |
| Integra Lifesciences Corporation | 1 | $37 |
| Kerecis Limited | 1 | $22 |
| Smith+Nephew | 1 | $20 |
| Glenmark Therapeutics Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVA, combined machine$9,060
- TISSUEBLUE$5,093
- PuraPly$1,800
- XEOMIN$384
- PROPEL$280
- ASCLERA$250
- SCOPIS ENT$174
- ENTELLUS - XPRESS ENT DILATION SYSTEM$155
- CLARIFIX$138
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$128
- BOTOX COSMETIC$123
- EXPAREL$119
How this compares
$15,798 in reported general payments places this provider in the 85th percentile of 729 otolaryngology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 100 | $1,008 |
| Nitro-BidNitroglycerin | 17 | $546 |
| Mupirocin | 43 | $297 |
| Minoxidil | 15 | $253 |
| Amoxicillin | 27 | $71 |
| Ondansetron OdtOndansetron | 17 | $61 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Fort Worth
- Marc DeanFort Worth$594K
- Jeremy WatkinsFort Worth$280K
- Sean CallahanFort Worth$105K
- John McIntyreFort Worth$41K
- Yadranko DucicFort Worth$31K
- Laurence ChuAustin$37.4M
- Mark ZafereoHouston$7.8M
- Neil GrossHouston$1.5M
- Chad McDuffieFrisco$1.5M
- Ian AlexanderBoerne$999K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.